Mabtech is a Swedish biotech company whose mission is to stimulate life science research, by providing the scientific community with optimized immunoassays and instruments, in particular tools for ELISpot, FluoroSpot, ELISA and multiplex. To that end, Mabtech develops and produces a wide range of monoclonal antibodies, kits, peptide pools, and instruments for in vitro applications. Founded in 1986, Mabtech currently operates from its offices in Europe and in North America, in collaboration with a network of distributors around the globe.